Paper658107
Pharmacokinetics of bendroflumenthiazide in hypertensive patients.
Beermann B and 3 others. Eur J Clin Pharmacol, 1978. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of bendroflumenthiazide in hypertensive patients. Papers, record 658107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/658107
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bendroflumethiazide | Major topic |
| Hypertension | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Creatinine | |
| Electrocardiography | |
| Female | |
| Heart Rate | |
| Humans | |
| Kinetics | |
| Male | |
| Metals | |
| Middle Aged | |
| Placebos |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,089,446 | Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. | Br Med J | 1975 | https://conductscience.org/library/papers/1089446 | PubMed |
| 2 | 14,079,660 | THE EFFECT OF CHLOROTHIAZIDE ON THE EXCRETION OF URIC ACID AND ELECTROLYTES BY THE CHICKEN. | J Pharmacol Exp Ther | 1963 | https://conductscience.org/library/papers/14079660 | PubMed |
| 3 | 14,096,389 | S35-LABELED BENDROFLUMETHIAZIDE IN HUMAN BEINGS: CLINICAL STUDIES. | Arch Intern Med | 1964 | https://conductscience.org/library/papers/14096389 | PubMed |
| 4 | 902,450 | Pharmacokinetics of bendroflumethiazide. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/902450 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,049,382 | Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic. | Curr Opin Cardiol | 2015 | https://conductscience.org/library/papers/26049382 | PubMed |
| 7,310,642 | Pharmacokinetics of bendroflumethiazide after low oral doses. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7310642 | PubMed |
| 7,056,277 | Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7056277 | PubMed |
| 6,993,083 | Clinical pharmacokinetics of diuretics. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6993083 | PubMed |
| 668,773 | Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/668773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/658107
GET https://conductscience.org/api/papers/v1/658107/authors